Financial Performance - The company's operating revenue for the reporting period is expected to be CNY 122.52 million, a decrease of 23.70% compared to the same period last year[4]. - The net profit attributable to shareholders is projected to be CNY -23.23 million, representing a decline of 1,011.52% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be CNY -29.52 million, down 231.06% from the previous year[4]. - The company’s basic earnings per share are expected to be CNY -0.21, a decrease of 950.00% compared to the previous year[4]. Assets and Equity - Total assets at the end of the reporting period are estimated to be CNY 395.28 million, a decrease of 6.71% from the beginning of the period[4]. - The equity attributable to shareholders is projected to be CNY 294.08 million, down 7.32% from the beginning of the period[4]. Market Conditions - The company faced intensified competition in the feed market due to the impact of African swine fever and capacity adjustments, leading to a decline in revenue and gross profit[5]. Financial Management - The company has increased provisions for bad debts due to financial pressures on clients in the downstream breeding industry[6]. - The company has lowered prices on some products, resulting in increased provisions for inventory depreciation[6]. Cautionary Note - The company warns that the financial data presented is preliminary and has not been audited, urging investors to be cautious[7].
大禹生物(871970) - 2024 Q4 - 年度业绩